Half-year profits at China Feihe could fall by more than a third, the infant-formula producer has warned.

The Hong Kong-listed company said yesterday (10 August) it expects its first-half net profit to drop by 23-36% year on year.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In a stock-exchange filing, the group pointed to the “low birth rate in China”, competition and an expected net loss from listed subsidiary YuanShengTai Dairy Farm.

China Feihe expects to book first-half revenue of around 9.58bn ($1.32bn) to 9.87bn yuan. A year earlier, the company posted half-year revenue of 9.67bn yuan.

In 2022, the business generated revenue of 21.31bn yuan and a net profit of 4.95bn yuan.

It expects to publish its first-half accounts by the end of the month.

Shares in China Feihe closed down 11.42% at HK$4.42.

China Feihe’s main products include infant milk formula products, adult milk-powder, liquid milk and goat milk infant formula.

The company’s formula brands include Astrobaby and Organic Zhenzhi.